Tuberculosis drug discovery: an in-house toxin blocks pathogenic bacterial growth

Tuberculosis causes more deaths worldwide every year than any other infectious disease, except COVID-19. Today, its treatment is getting increasingly challenging due to the rise of antibiotic-resistant variants of disease-causing bacteria. We discovered an in-house toxin that blocks pathogenic bacterial growth, offering potential clues for future drug design. - submission by Yiming Cai, Ben Usher